Suppr超能文献

由于依赖肺毛细血管楔压而非左心室舒张末期压力导致肺动脉高压的误诊。

Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure.

作者信息

Halpern Scott D, Taichman Darren B

机构信息

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.

Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.

出版信息

Chest. 2009 Jul;136(1):37-43. doi: 10.1378/chest.08-2784. Epub 2009 Mar 2.

Abstract

BACKGROUND

Pulmonary arterial hypertension (PAH) is typically distinguished from pulmonary venous hypertension (PVH) by documenting a pulmonary capillary wedge pressure (PCWP) <or= 15 mm Hg. However, PCWP has uncertain utility in establishing PAH. We sought to determine the calibration, discrimination, and diagnostic accuracy of PCWP, using simultaneously measured left ventricular end-diastolic pressure (LVEDP) as the "gold standard."

METHODS

We examined hemodynamic data from the 11,523 unique patients undergoing simultaneous right-heart and left-heart catheterization at a large academic center from 1998 to 2007.

RESULTS

Among 4,320 patients (37.5%) with pulmonary hypertension (PH) [mean pulmonary artery pressure, >or= 25 mm Hg], hemodynamic data were complete for 3,926 patients (90.9%). Of these, 580 patients (14.8%) met the criteria for PAH with a PCWP <or= 15 mm Hg, but 310 of these patients (53.5%) had an LVEDP > 15 mm Hg. Such discrepancies remained common among patients with a pulmonary vascular resistance > 3 Wood units and those being catheterized specifically to evaluate PH. PCWP provided moderate discrimination between patients with high vs normal LVEDP (area under the receiver operating characteristic curve, 0.84; 95% confidence interval, 0.81 to 0.86) but was poorly calibrated to LVEDP (Bland-Altman limits of agreement, - 15.2 to 9.5 mm Hg; Hosmer-Lemeshow goodness-of-fit chi(2) statistic, 155.4; p < 0.0001).

CONCLUSIONS

Roughly half of the patients presumed to have PAH based on PCWP may be found to have PVH based on LVEDP. Reliance on PCWP may result in the dangerous or cost-ineffective use of pulmonary vasodilators for patients with left-heart disease. Furthermore, without assessing LVEDP, investigators may include patients with left-heart disease in therapeutic trials of PAH drugs, thereby limiting their ability to detect beneficial drug effects.

摘要

背景

肺动脉高压(PAH)通常通过记录肺毛细血管楔压(PCWP)≤15mmHg与肺静脉高压(PVH)相区分。然而,PCWP在诊断PAH方面的效用并不确定。我们试图以同时测量的左心室舒张末期压力(LVEDP)作为“金标准”,来确定PCWP的校准、鉴别能力及诊断准确性。

方法

我们研究了1998年至2007年在一个大型学术中心接受同步右心和左心导管检查的11523例患者的血流动力学数据。

结果

在4320例(37.5%)患有肺动脉高压(PH)[平均肺动脉压≥25mmHg]的患者中,3926例(90.9%)患者的血流动力学数据完整。其中,580例(14.8%)患者符合PAH标准,PCWP≤15mmHg,但其中310例(53.5%)患者的LVEDP>15mmHg。在肺血管阻力>3伍德单位的患者以及专门为评估PH而进行导管检查的患者中,这种差异仍然很常见。PCWP在LVEDP高与正常的患者之间具有中等鉴别能力(受试者工作特征曲线下面积为0.84;95%置信区间为0.81至0.86),但与LVEDP校准不佳(Bland-Altman一致性界限为-15.2至9.5mmHg;Hosmer-Lemeshow拟合优度卡方统计量为155.4;p<0.0001)。

结论

根据PCWP推测患有PAH的患者中,约有一半基于LVEDP可能被发现患有PVH。依赖PCWP可能会导致对左心疾病患者危险地或成本效益不佳地使用肺血管扩张剂。此外,在不评估LVEDP的情况下,研究人员可能会将左心疾病患者纳入PAH药物治疗试验,从而限制了他们检测有益药物效果的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验